Logo image of ALSGD.PA

SPINEGUARD SA (ALSGD.PA) Stock Fundamental Analysis

EPA:ALSGD - Euronext Paris - Matif - FR0011464452 - Common Stock - Currency: EUR

0.193  +0 (+0.63%)

Fundamental Rating

2

Overall ALSGD gets a fundamental rating of 2 out of 10. We evaluated ALSGD against 55 industry peers in the Health Care Equipment & Supplies industry. ALSGD may be in some trouble as it scores bad on both profitability and health. ALSGD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALSGD has reported negative net income.
In the past year ALSGD has reported a negative cash flow from operations.
ALSGD had negative earnings in each of the past 5 years.
In the past 5 years ALSGD reported 4 times negative operating cash flow.
ALSGD.PA Yearly Net Income VS EBIT VS OCF VS FCFALSGD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1M -2M -3M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -41.75%, ALSGD is doing worse than 83.64% of the companies in the same industry.
ALSGD's Return On Equity of -86.49% is on the low side compared to the rest of the industry. ALSGD is outperformed by 74.55% of its industry peers.
Industry RankSector Rank
ROA -41.75%
ROE -86.49%
ROIC N/A
ROA(3y)-24.4%
ROA(5y)-23%
ROE(3y)-50.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALSGD.PA Yearly ROA, ROE, ROICALSGD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10K 20K 30K

1.3 Margins

ALSGD has a better Gross Margin (73.25%) than 78.18% of its industry peers.
In the last couple of years the Gross Margin of ALSGD has declined.
The Profit Margin and Operating Margin are not available for ALSGD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5Y-1.99%
ALSGD.PA Yearly Profit, Operating, Gross MarginsALSGD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

More info and screens

2

2. Health

2.1 Basic Checks

ALSGD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALSGD has more shares outstanding
The number of shares outstanding for ALSGD has been increased compared to 5 years ago.
ALSGD has a better debt/assets ratio than last year.
ALSGD.PA Yearly Shares OutstandingALSGD.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
ALSGD.PA Yearly Total Debt VS Total AssetsALSGD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -4.87, we must say that ALSGD is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -4.87, ALSGD is doing worse than 81.82% of the companies in the same industry.
ALSGD has a Debt/Equity ratio of 0.57. This is a neutral value indicating ALSGD is somewhat dependend on debt financing.
ALSGD has a Debt to Equity ratio (0.57) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z -4.87
ROIC/WACCN/A
WACC7.47%
ALSGD.PA Yearly LT Debt VS Equity VS FCFALSGD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M

2.3 Liquidity

A Current Ratio of 1.34 indicates that ALSGD should not have too much problems paying its short term obligations.
ALSGD has a Current ratio of 1.34. This is comparable to the rest of the industry: ALSGD outperforms 47.27% of its industry peers.
ALSGD has a Quick Ratio of 1.01. This is a normal value and indicates that ALSGD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.01, ALSGD is in line with its industry, outperforming 50.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.01
ALSGD.PA Yearly Current Assets VS Current LiabilitesALSGD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

More info and screens

3

3. Growth

3.1 Past

ALSGD shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.44%.
Looking at the last year, ALSGD shows a very negative growth in Revenue. The Revenue has decreased by -14.43% in the last year.
Measured over the past years, ALSGD shows a very negative growth in Revenue. The Revenue has been decreasing by -10.65% on average per year.
EPS 1Y (TTM)2.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.29%
Revenue 1Y (TTM)-14.43%
Revenue growth 3Y-3.85%
Revenue growth 5Y-10.65%
Sales Q2Q%9.48%

3.2 Future

Based on estimates for the next years, ALSGD will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.30% on average per year.
ALSGD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.16% yearly.
EPS Next Y-44.99%
EPS Next 2Y-1.77%
EPS Next 3Y11.3%
EPS Next 5YN/A
Revenue Next Year3.81%
Revenue Next 2Y15.25%
Revenue Next 3Y18.16%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALSGD.PA Yearly Revenue VS EstimatesALSGD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
ALSGD.PA Yearly EPS VS EstimatesALSGD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALSGD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALSGD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSGD.PA Price Earnings VS Forward Price EarningsALSGD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALSGD.PA Per share dataALSGD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.77%
EPS Next 3Y11.3%

More info and screens

0

5. Dividend

5.1 Amount

ALSGD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPINEGUARD SA

EPA:ALSGD (3/7/2025, 7:00:00 PM)

0.193

+0 (+0.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-09 2024-10-09
Earnings (Next)04-15 2025-04-15/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.79M
Analysts84.44
Price Target0.77 (298.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-16.67%
EPS NY rev (3m)-16.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-13.72%
Revenue NY rev (3m)-13.72%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.38
P/FCF N/A
P/OCF N/A
P/B 2.47
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.08
BVpS0.08
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -41.75%
ROE -86.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.25%
FCFM N/A
ROA(3y)-24.4%
ROA(5y)-23%
ROE(3y)-50.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5Y-1.99%
F-Score3
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 390.26%
Cap/Sales 24.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.01
Altman-Z -4.87
F-Score3
WACC7.47%
ROIC/WACCN/A
Cap/Depr(3y)225.59%
Cap/Depr(5y)162.09%
Cap/Sales(3y)14.53%
Cap/Sales(5y)10.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.29%
EPS Next Y-44.99%
EPS Next 2Y-1.77%
EPS Next 3Y11.3%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.43%
Revenue growth 3Y-3.85%
Revenue growth 5Y-10.65%
Sales Q2Q%9.48%
Revenue Next Year3.81%
Revenue Next 2Y15.25%
Revenue Next 3Y18.16%
Revenue Next 5YN/A
EBIT growth 1Y-41.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year11.42%
EBIT Next 3Y21.55%
EBIT Next 5YN/A
FCF growth 1Y-71.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.78%
OCF growth 3YN/A
OCF growth 5YN/A